ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,005Medicare Part D Prescriptions Filled, Including Refills

Rank: 416 out of 5176

$1.4M Total Retail Price of All Prescriptions

Rank: 125 out of 5176

274 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

3% of this provider’s 11,683 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

70% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$117 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

44 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
EVISTA 916 879 1 65
AMLODIPINE BESYLATE 537 499 2 2
NEXIUM 526 518 3 16
LIDODERM 346 346 4 59
SINGULAIR 311 311 5 62
CRESTOR 282 275 6 15
DIOVAN HCT 281 273 7 39
PROMETHAZINE HCL 232 231 R 8 221
BYSTOLIC 222 221 9 96
NAMENDA 220 220 10 47
NASONEX 205 204 11 178
TRIAMCINOLONE ACETONIDE 199 185 12 125
AVODART 187 187 13 107
MELOXICAM 187 179 13 53
BENICAR 179 179 15 100
JANUVIA 173 173 16 25
TAMSULOSIN HCL 171 171 17 20
LOSARTAN POTASSIUM 166 158 18 14
LEVOTHYROXINE SODIUM 164 153 19 4
SIMVASTATIN 164 145 19 1
DIOVAN 158 158 21 19
METOPROLOL SUCCINATE 158 158 21 11
DEXILANT 148 148 23 118
MONTELUKAST SODIUM 142 136 24 123
CLOPIDOGREL 141 135 25 26
PLAVIX 140 140 26 29
PATADAY 132 130 27 220
ACTOS 131 129 28 85
OMEPRAZOLE 118 108 29 3
MECLIZINE HCL 116 116 30 81
LOSARTAN-HYDROCHLOROTHIAZIDE 113 105 31 35
CELEBREX 113 113 31 80
VOLTAREN 112 112 33 97
LOVAZA 107 107 34 43
SPIRIVA 102 100 35 54
EXFORGE 98 98 36 126
TRILIPIX 96 96 37 187
ULORIC 92 92 38 280
FLUTICASONE PROPIONATE 91 89 39 38
ALENDRONATE SODIUM 90 82 40 18
FLECTOR 85 79 41 282
ATORVASTATIN CALCIUM 84 84 42 9
SYNTHROID 83 75 43 33
BENICAR HCT 83 83 43 110
PROPRANOLOL HCL 82 81 45 199
AMMONIUM LACTATE 81 78 46 91
FUROSEMIDE 75 75 47 8
EXELON 72 72 48 162
GLYBURIDE-METFORMIN HCL 70 70 R 49 76
ACTOPLUS MET 68 68 50 268
ALLOPURINOL 67 67 51 41
HYDROCHLOROTHIAZIDE 63 63 52 10
TEKTURNA 62 62 53 255
LIDOCAINE 62 58 53 179
AMITIZA 59 59 55 197
ALBUTEROL SULFATE 59 52 55 99
METFORMIN HCL 58 58 57 7
WELCHOL 56 56 58 230
FLUOCINONIDE 56 54 58 165
CLOTRIMAZOLE-BETAMETHASONE 55 55 60 94
CYMBALTA 54 52 61 90
POLYETHYLENE GLYCOL 3350 53 53 62 74
VALSARTAN-HYDROCHLOROTHIAZIDE 51 48 63 292
OLANZAPINE 50 47 64 140
MICARDIS 50 44 64 154
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 4, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.